The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic Mice
Open accessAbstract
Overexpression is the most common abnormality of receptor tyrosine kinases (RTKs) in human tumors. It is presumed that overexpression leads to constitutive activation of RTKs, but the mechanism of that activation has been uncertain. Here we show that overexpression of the Met RTK allows activation of the receptor by cell attachment and that this form of activation can be tumorigenic. Transgenic mice that overexpressed Met in hepatocytes developed hepatocellular carcinoma (HCC), one of the human tumors in which Met has been implicated previously. The tumorigenic Met was activated by cell attachment rather than by ligand. Inactivation of the transgene led to regression of even highly advanced tumors, apparently mediated by apoptosis and cessation of cellular proliferation. These results reveal a previously unappreciated mechanism by which the tumorigenic action of RTKs can be mediated, provide evidence that Met may play a role in both the genesis and maintenance of HCC, and suggest that Met may be a beneficial therapeutic target in tumors that overexpress the receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Self-citationSchmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G., & Comoglio, P. M. (1994) · Cell · doi:10.1016/0092-8674(94)90318-2 · Cited by 991
Molecular cloning of a new transforming gene from a chemically transformed human cell line
Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., & Vande Woude, G. F. (1984) · Nature · doi:10.1038/311029a0 · Cited by 989
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lübbert, H., & Bujard, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10933 · Cited by 778
Naldini, L., Vigna, E., Narsimhan, R. P., Gaudino, G., Zarnegar, R., Michalopoulos, G. K., & Comoglio, P. M. (1991) · PubMed · Cited by 698
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.
Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R., & Michalopoulos, G. K. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07836.x · Cited by 660
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
Birchmeier, C., & Gherardi, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01359-2 · Cited by 597
Weidner, K. M., Di Cesare, S., Sachs, M., Brinkmann, V., Behrens, J., & Birchmeier, W. (1996) · Nature · doi:10.1038/384173a0 · Cited by 576
Park, M., Dean, M., Kaul, K., Braun, M. J., Gonda, M. A., & Vande Woude, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6379 · Cited by 561
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
Boccaccio, C., Andò, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., & Comoglio, P. M. (1998) · Nature · doi:10.1038/34657 · Cited by 519
Okuda, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80428-6 · Cited by 443
PARENCHYMAL CELLS FROM ADULT RAT LIVER IN NONPROLIFERATING MONOLAYER CULTURE
Montgomery Bissell, D., Hammaker, L. E., & Meyer, U. A. (1973) · The Journal of Cell Biology · doi:10.1083/jcb.59.3.722 · Cited by 429
Transient excess of MYC activity can elicit genomic instability and tumorigenesis
Felsher, D. W., & Bishop, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3940 · Cited by 419
Self-citationSomatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Di Renzo, M. F., Olivero, M., Martone, T., Maffe, A., Maggiora, P., De Stefani, A., Valente, G., Giordano, S., Cortesina, G., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203455 · Cited by 332
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., & Vande Woude, G. F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5152 · Cited by 312
Prat, M., Narsimhan, R. P., Crepaldi, T., Rita Nicotra, M., Natali, P. G., & Comoglio, P. M. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490302 · Cited by 287
Park, W. S., Dong, S. M., Kim, S. Y., Na, E. Y., Shin, M. S., Pi, J. H., Kim, B. J., Bae, J. H., Hong, Y. K., Lee, K. S., et al. (1999) · PubMed · Cited by 251
Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins
Kinoshita, T., Tashiro, K., & Nakamura, T. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92733-2 · Cited by 245
Interactions between mitogenic stimuli, or, a thousand and one connections
Schwartz, M. A., & Baron, V. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80026-x · Cited by 243
Royal, I., & Park, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27780 · Cited by 237
The mutationally activated Met receptor mediates motility and metastasis
Jeffers, M., Fiscella, M., Webb, C. P., Anver, M., Koochekpour, S., & Vande Woude, G. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14417 · Cited by 224
Biosynthesis of the protein encoded by the c-met proto-oncogene.
Giordano, S., Renzo, M. F. D., Narsimhan, R. P., Cooper, C. S., Rosa, C., & Comoglio, P. M. (1989) · PubMed · Cited by 217
Sundberg, C., & Rubin, K. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.4.741 · Cited by 211
The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.
Naldini, L., Vigna, E., Ferracini, R., Longati, P., Gandino, L., Prat, M., & Comoglio, P. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1793 · Cited by 185
Redfern, C. H., Coward, P., Degtyarev, M. Y., Lee, E. K., Kwa, A. T., Hennighausen, L., Bujard, H., Fishman, G. I., & Conklin, B. R. (1999) · Nature Biotechnology · doi:10.1038/6165 · Cited by 178
Gonzatti-Haces, M., Seth, A., Park, M., Copeland, T., Oroszlan, S., & Vande Woude, G. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.21 · Cited by 177
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
Ponzetto, C., Giordano, S., Peverali, F. A., Valle, G. D., Ml, A., Vaula, G., & Comoglio, P. M. (1991) · PubMed · Cited by 172
Amicone, L. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.495 · Cited by 168
Ferracini, R., Longati, P., Naldini, L., Vigna, E., & Comoglio, P. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55031-6 · Cited by 143
Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
Bhargava, M., Joseph, A., Knesel, J., Halaban, R., Li, Y., Pang, S. Y.-Y., Goldberg, I. D., Setter, E., Donovan, M. A., & Zarnegar, R. (1992) · PubMed · Cited by 140
Juliano, R. L. (1996) · BioEssays · doi:10.1002/bies.950181110 · Cited by 136
Met–HGF/SF: Tumorigenesis, Invasion and Metastasis
Woude, G. F. V., Jeffers, M., Cortner, J., Alvord, G., Tsarfaty, I., & Resau, J. H. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515457.ch8 · Cited by 124
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene.
Iyer, A., Kmiecik, T. E., Park, M., Daar, I. O., Blair, D. G., Dunn, K., Sutrave, P., Ihle, J. N., Bodescot, M., & Woude, G. V. (1990) · PubMed · Cited by 118
Hepatocyte growth factor/scatter factor‐induced intracellular signalling
Stuart, K. A., Riordan, S. M., Lidder, S., Crostella, L., Williams, R. L., & Skouteris, G. G. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00138.x · Cited by 116
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
Liang, T. J., Reid, A. E., Xavier, R. J., Cardiff, R. D., & Wang, T. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118744 · Cited by 115
A point mutation in the MET oncogene abrogates metastasis without affecting transformation
Giordano, S., Bardelli, A., Zhen, Z., Ménard, S., Ponzetto, C., & Comoglio, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13868 · Cited by 92
Danilkovitch‐Miagkova, A., Angeloni, D., Skeel, A., Donley, S., Lerman, M. I., & Leonard, E. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000028200 · Cited by 89
Noguchi, O., Enomoto, N., Ikeda, T., Kobayashi, F., Marumo, F., & Sato, C. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80006-7 · Cited by 56
Expression of the HGF/SF Receptor, c-met, and Its Ligand in Human Colorectal Cancers
Hiscox, S., Hallett, M. B., Jiang, W. G., Puntis, M. C. A., & Nakamura, T. (1997) · Cancer Investigation · doi:10.3109/07357909709047592 · Cited by 52
Flipping the oncogene switch: illumination of tumor maintenance and regression
Chin, L., & DePinho, R. A. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01968-x · Cited by 34
Cited by
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Sensing the environment: a historical perspective on integrin signal transduction
Miranti, C. K., & Brugge, J. S. (2002) · Nature Cell Biology · doi:10.1038/ncb0402-e83 · Cited by 859
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
Metadata
- Authors
- Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2001-05-28
- Volume
- 153
- Issue
- 5
- Pages
- 1023-1034
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2054605144
- Cited by
- 281
- References
- 45
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.